Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's diseaseYa Wei, Huile Gao|Acta Pharmaceutica Sinica B|2025Cited by 39
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trialXiuchun Chen, Zhenzhen Liu, Jianghua Qiao et al.|The Lancet Oncology|2024Cited by 32